
Sign up to save your podcasts
Or
Kelley Kozma, DO, MS, Medical Director for Oncology at Cleveland Clinic Martin Health in Florida, to discuss how targeted therapies, next generation sequencing, and personalized medicine are transforming breast cancer care. Listen as Dr. Kozma shares how innovations like HER2-low targeting, liquid biopsy, and circulating tumor DNA are helping clinicians tailor treatments and improve outcomes.
5
2424 ratings
Kelley Kozma, DO, MS, Medical Director for Oncology at Cleveland Clinic Martin Health in Florida, to discuss how targeted therapies, next generation sequencing, and personalized medicine are transforming breast cancer care. Listen as Dr. Kozma shares how innovations like HER2-low targeting, liquid biopsy, and circulating tumor DNA are helping clinicians tailor treatments and improve outcomes.
8,733 Listeners
500 Listeners
704 Listeners
58 Listeners
2,428 Listeners
3,338 Listeners
56,433 Listeners
90 Listeners
4,878 Listeners
3,528 Listeners
8,046 Listeners
515 Listeners
368 Listeners
252 Listeners
184 Listeners